Hester Biosciences Limited has issued a corrigendum to the notice for its 39th Annual General Meeting (AGM), scheduled for July 21, 2026. The corrigendum addresses a typographical error on page 17 of the original AGM notice concerning the remuneration terms for the re-appointment of the Executive Director. Specifically, the gross salary for the Executive Director has been corrected to ₹10 lakh per month, an increase from the previously stated ₹8.40 lakh per month. This correction aligns with the remuneration terms approved by the Board of Directors. The company assures that this change is solely to rectify an inadvertent clerical error and does not alter the approved remuneration structure. The 39th AGM will be held via Video Conference/Other Audio Visual Means. The agenda includes the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026, declaration of a dividend of ₹11 per equity share, re-appointment of Mr. Sanjiv Gandhi as a Director, and ratification of the remuneration for the Cost Auditors for the financial year ending March 31, 2027. A special business item on the agenda is the re-appointment of Ms. Priya Gandhi as Executive Director for a period of three years, starting from October 28, 2026, to October 27, 2029. The company has also provided extensive details regarding dividend payments, tax deductions at source, and procedures for attending the AGM through virtual means.
